Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy

被引:34
|
作者
Nassisi, Marco [1 ]
Lavia, Carlo [1 ]
Alovisi, Camilla [1 ]
Musso, Luca [1 ]
Eandi, Chiara M. [1 ]
机构
[1] Univ Torino, Dept Surg Sci, I-10126 Turin, Italy
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 11期
关键词
choriocapillaris; retina; choroid; central serous chorioretinopathy; photodynamic therapy; COHERENCE TOMOGRAPHIC ANGIOGRAPHY; INDOCYANINE GREEN ANGIOGRAPHY; CHOROIDAL NEOVASCULARIZATION; OCT ANGIOGRAPHY; VERTEPORFIN;
D O I
10.3390/ijms18112468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Although photodynamic therapy (PDT) has become the standard treatment for central serous chorioretinopathy (CSC), its mechanism of action remains unclear. It is assumed that PDT induces short-term choriocapillaris (CC) occlusion and long-term choroidal vascular remodeling. In this paper, we describe the short-term CC changes induced by Half-Dose PDT (HD-PDT) in chronic CSC using optical coherence tomography-angiography (OCTA). Methods: This is a prospective interventional case series. Chronic CSC eyes underwent Spectral-Domain OCT, Fundus Autofluorescence, FA, ICGA (Heidelberg Spectralis, Heidelberg, Germany) and OCTA (RTVue XR Avanti with AngioVue; Optovue Inc., Fremont, CA, USA) before HD-PDT, with follow-up after one hour, one week, and one month. Vascular changes after PDT were analyzed within the CC layer. The CC vessel density was defined as the percentage of an area occupied by flow pixels, using Image J software to obtain measurements by applying a grey level threshold. All pixels with a grey level above the threshold were considered as indicators of blood flow. Results: 20 eyes of 19 patients were included. At baseline the mean CC vessel density was 94.87 +/- 2.32%. It significantly differed from the density at 1 week and 1 month (92.79 +/- 3.16% and 95.55 +/- 2.05%, p < 0.001, respectively), but not with values at 1 h (94.8 +/- 2.28%, p = 0.516). Conclusions: CC vessel density was significantly reduced at 1 week as compared with baseline, suggesting a possible short-term effect of PDT on CC perfusion. After 1 month however, the CC vessel density was even higher than the baseline, probably due to a CC recovery. OCTA seems to be useful in the visualization of CC vessels and in confirming the mechanism of action of PDT treatment in eyes with chronic CSC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] RETINAL SENSITIVITY AFTER PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY Short-Term Results
    Fujita, Kyoko
    Yuzawa, Mitsuko
    Mori, Ryusaburou
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (04): : 772 - 778
  • [2] Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [3] Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Alovisi, Camilla
    Piccolino, Felice Cardillo
    Nassisi, Marco
    Eandi, Chiara M.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [4] Choriocapillaris Changes Imaged by OCT Angiography After Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Fujita, Kyoko
    Kawamura, Akiyuki
    Yuzawa, Mitsuko
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (04) : 302 - 310
  • [5] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Servillo, Andrea
    Sacconi, Riccardo
    Zucchiatti, Ilaria
    Grachova, Elena
    Querques, Lea
    Prascina, Francesco
    Tombolini, Beatrice
    Dorin, Giorgio
    Mainster, Martin
    Bandello, Francesco
    Querques, Giuseppe
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 2199 - 2208
  • [6] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Andrea Servillo
    Riccardo Sacconi
    Ilaria Zucchiatti
    Elena Grachova
    Lea Querques
    Francesco Prascina
    Beatrice Tombolini
    Giorgio Dorin
    Martin Mainster
    Francesco Bandello
    Giuseppe Querques
    Ophthalmology and Therapy, 2023, 12 : 2199 - 2208
  • [7] Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
    Karakus, S. H.
    Basarir, B.
    Pinarci, E. Y.
    Kirandi, E. U.
    Demirok, A.
    EYE, 2013, 27 (05) : 612 - 620
  • [8] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
  • [9] Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy
    Torres-Costa, Sonia
    Penas, Susana
    Cerqueira, Ana Rita
    Brandao, Elisete
    Carneiro, Angela
    Rocha-Sousa, Amandio
    Falcao-Reis, Fernando
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 34
  • [10] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863